Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation

Back

ESC Premium Access

Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation

Session: Anti-arrhythmic drug therapy: new concepts on old drugs

Topic: Antiarrhythmic Pharmacotherapy

Speaker: Doctor M. Mihajlovic (Belgrade, RS)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Doctor Miroslav Mihajlovic

University Clinical Center of Serbia, Belgrade (Serbia)

0 follower

3 more presentations in this session

State of the Art from history to future of anti-arrhythmic drugs

Speaker: Professor J. Camm (London, GB)

Access

Slides

Video

Efficacy and limitations of quinidine therapy in patients with Brugada Syndrome

Speaker: Doctor A. Mazzanti (Pavia, IT)

A prospective, multicenter, nationwide, observational study of flecainide controlled release on the quality of life of patients with atrial fibrillation in Greece, the REFLEC-CR study

Speaker: Doctor S. Tzeis (Athens, GR)

Access the full session

Anti-arrhythmic drug therapy: new concepts on old drugs

Speakers: Doctor M. Mihajlovic, Professor J. Camm, Doctor A. Mazzanti, Doctor S. Tzeis

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation

About the speaker

Doctor Miroslav Mihajlovic

3 more presentations in this session

State of the Art from history to future of anti-arrhythmic drugs

Efficacy and limitations of quinidine therapy in patients with Brugada Syndrome

A prospective, multicenter, nationwide, observational study of flecainide controlled release on the quality of life of patients with atrial fibrillation in Greece, the REFLEC-CR study

Access the full session

Anti-arrhythmic drug therapy: new concepts on old drugs

About the event

ESC Congress 2019

ESC 365 is supported by